Key result
Hospital CHF disease management practices linked to up to ~4-day differences in length of stay.
Why the study?
Hospital length of stay is a key determinant of hospital costs in congestive heart failure, and the economic benefits of improved disease-specific management programs on length of stay have not been quantified.
Do improved disease management strategies reduce hospital length of stay in patients with congestive heart failure?
Population
5242 records of patients hospitalized for CHF in the United States
Comparison
Improved disease-specific management programs vs standard hospital management practices
Design
Observational study controlling for patient-specific characteristics and hospital fixed effects
Authors
Loading...
These observational associations should not yet change practice; leaves open whether optimizing strategies shortens heart failure stays.
Observational (n=5,242)
Yes
Do improved disease management strategies reduce hospital length of stay in patients with congestive heart failure?
Differences in disease management strategies across hospitals significantly impact length of stay for heart failure patients, suggesting substantial potential economic benefits from adopting optimal practices.
Simons et al. (1996) conducted an observational in Congestive heart failure (n=5,242). Disease-specific management programs vs. Reference hospital practices was evaluated on Hospital length of stay (LOS). Differences in hospital-specific disease management practices for congestive heart failure were associated with length of stay variations ranging from -3.41 to 4.33 days.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: